Research Article
Volume 6 Issue 1 - 2022
Incidence of Renal Nephropathy after Kidney Transplantation in Patients with or without Pre-Transplant Type II Diabetes
Mahmoud Mansour1*, Sultan Alanazi1, Mohammad Alenazi1, Alhomaidi Alghuwairy1, Nataleen A. Albekairy2, Yousef Al-Rajhi3, Abdulmalik Alkatheri1, Shmeylan Al-Harbi1 and Abdulkareem M Albekairy1
1College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
2College of Medicine,, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
3Pharmaceutical Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, KSA
*Corresponding Author: Mahmoud Mansour, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Received: May 23, 2022; Published: June 29, 2022


Objectives: A remarkable improvement of impaired patient’s kidney function is often observed after renal transplantation. long-term renal allograft survival is ensured on preserving improved kidney function. However, there are different risk factors; one of the major risk factor is diabetic nephropathy (DN). Therefore, the goal of the present study was to predict incidence of diabetic nephropathy after kidney transplantation within the first 8 months.

Methods: To investigate the incidence of diabetic nephropathy after renal transplantation in patients with or without type 2 diabetes, a retrospective analyzed study was performed on fifty-two renal transplant patients, 33 with type 2 diabetes pre-transplant and 19 non-diabetic, they underwent kidney transplantation in 2009 to 2019 in King Abdulaziz Medical City- National Guard and were evaluated consecutively for 8-month before incidence of nephropathy and up to 8 months’ post-nephropathy. Time course of changes in kidney functions as, measurements of serum creatinine (Scr), blood urea nitrogen (BUN), microalbuminuria, were recorded before and after incidence of different nephropathy. Estimated glomerular filtration rate (eGFR) was also reported. In addition, age, anthropometric factors and causes of DN were analyzed.

Results: There were no significant difference in all investigated parameters 8 months before and 8 months after incidence of different types of nephropathy as (IgA, Diabetic, Glomerular and others) based on monthly assessment. However, the incidence of nephropathy in post-transplanted non-diabetic patients are associated with a remarkable higher level of serum creatinine, BUN and microalbuminuria and reduction in eGFR starting from first month as compared with non-diabetic without nephropathy. While a profound elevation of serum creatinine and BUN in month 2 and 5 respectively and significant lowering in GFR in month 6 were associated with the incidence of nephropathy in diabetic post-transplant kidney as compared with diabetic non-nephropathy post-transplant patients. Comparing incidence of nephropathy in post-transplant diabetic and non-diabetic patients, serum creatinine started to increase significantly from month 5 while others parameters were kept elevated but non-significant. However, all tested parameters were kept in normal ranges between post-transplant diabetic and non-diabetic patients without nephropathy.

Conclusion: In non-diabetic patients, a consistent significant elevation of serum creatinine, BUN and microalbuminuria and reduction in eGFR starting from first month were associated with incidence of nephropathy in post-transplanted kidney. While in diabetic patients a significant elevation of serum creatinine was noticed in month 2. The clinical use of eGFR and serum creatinine may aid in predicting incidence of early diabetic nephropathy.


Keywords: Incidence of Renal Nephropathy; Kidney Transplantation; Pre-Transplant Type II Diabetes


  1. Hariharan S., et al. “Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry”. American Journal of Kidney Diseases6 (1998): 928-931.
  2. Burgos P., et al. “Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation”. Arthritis and Rheumatology9 (2009): 2757-2766.
  3. Artz MA., et al. “Time course of proteinuria after living-donor kidney transplantation”. Transplantation 76 (2003): 421-425.
  4. Calne RY. “Cyclosporin in cadaveric renal transplantation: 5 year follow-up of a multicenter trial”. Lancet 2 (1987): 506.
  5. First MR. “Renal allograft survival after 1 and 10 years: comparison between pre-cyclosporin and cyclosporin data”. Nephrology Dialysis Transplantation 9 (1993): 90.
  6. Canafax DM., et al. “The benefits of immunosuppression drug combination for diabetic recipients of cadaver and HLA mismatched related renal allografts”. Transplantation Proceedings 18 (1986): 1728.
  7. Cheigh JS., et al. “Kidney transplantation in insulin dependent diabetic patients: improved survival and rehabilitation”. Transplantation Proceedings 21 (1989): 2016.
  8. Khauli RB., et al. “A critical look at survival of diabetes with end-stage renal disease: transplantation versus dialysis therapy”. Transplantation 41 (1986): 598.
  9. Catalano C., et al. “Renal replacement treatment for diabetic patients in New Castle upon Tyne and Northern region”. British Medical Journal 301 (1990): 535.
  10. Najarian JS., et al. “Survival into the second decade following kidney transplantation in type I diabetic patients”. Transplantation Proceedings 21 (1989): 2012.
  11. Mauer SM., et al. “Immunopathology of renal extracellular membranes in kidneys transplanted into patients with diabetes mellitus”. Diabetes 25 (1976): 709.
  12. Mauer SM., et al. “Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus”. The New England Journal of Medicine 295 (1976): 916.
  13. “KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease”. American Journal of Kidney Diseases 49.2-2 (2007): S12-S154.
  14. NJ Radcliffe., et al. “Clinical predictive factors in diabetic kidney disease progression”. Journal of Diabetes Investigation (2016).
  15. E Espinel., et al. “Renal biopsy in type 2 diabetic patients”. Journal of Clinical Medicine5 (2015): 998-1009.
  16. Pavan M., et al. “Early recurrence of diabetic nodular sclerosis in a kidney transplant recipient”. Iranian Journal of Kidney Disease3 (2012): 219-221.
  17. Akioka K., et al. “Long‐term outcome of renal transplantation in focal glomerulo sclerosis”. Transplantation Proceedings9 (2006): 2819-2822.
  18. Celtik A., et al. “Recurrent lupus nephritis after transplantation: Clinico-pathological evaluation with protocol biopsies”. Nephrology7 (2016): 601-607.
  19. Cimeno A., et al. “Diabetic nephropathy after kidney transplantation in patients with pretransplantation type II diabetes: A retrospective case series study from a high-volume center in the United States”. Clinical Transplantation12 (2018): e13425.
  20. EBPG (European Expert Group on Renal Transplantation); European Renal Association (ERA-EDTA); European Society for Organ Transplantation (ESOT). European best practice guidelines for renal transplantation (part 1”. Nephrology Dialysis Transplantation7 (2000): 1-85.
  21. Nieto T., et al. “Renal transplantation in adults”. BMJ 355 (2016): i6158.
  22. Mauer SM., et al. “The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients”. Diabetes 32 (1983): 948-952.
  23. Osterby R., et al. “Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Early glomer ulopathy”. Diabetologia 34 (1991): 668-674.
  24. Barbosa J., et al. “Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulindependent diabetic kidney transplant recipients”. The Journal of the American Medical Association 272 (1994): 600-606.
  25. Bohman SO., et al. “Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation”. Transplantation Proceedings 19 (1987): 2290-2293.
  26. Mauer SM., et al. “Longterm study of normal kidneys transplanted into patients with type I diabetes”. Diabetes 38 (1989): 516-523.
  27. Bhalla V., et al. “Recurrent and de novo diabetic nephropathy in renal allografts”. Transplantation 75 (2003): 66-71.
  28. Webster AC., et al. “Chronic kidney disease”. Lancet 389 (2017): 1238-1252.
  29. Mauer SM., et al. “Structural-functional relationships in diabetic nephropathy”. Journal of Clinical Investigation 74 (1984): 1143-1155.
  30. Adler S. “Diabetic nephropathy: linking histology, cell biology, and genetics”. Kidney International 66 (2004): 2095-2106.
  31. Tonneijck L., et al. “Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment”. Journal of the American Society of Nephrology 28 (2017): 1023-1039.
  32. Steinke JM., et al. “International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients”. Diabetes 54 (2005): 2164-2171.
  33. Mauer M., et al. “Renal and retinal effects of enalapril and losartan in type 1 diabetes”. The New England Journal of Medicine 361 (2009): 40-51.
  34. Coca SG., et al. “Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and metaanalysis intensive glucose control in type 2 diabetes”. Archives of Internal Medicine 172 (2012): 761-769.
  35. Coemans M., et al. “Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study 4 (2019): 625-634.
  36. Hariharan S., et al. “Diabetic nephropathy after renal transplantation. Clinical and pathologic features”. Transplantation 62 (1996): 632-635.
  37. Najarian JS., et al. “Longterm survival following kidney transplantation in 100 type I diabetic patients”. Transplantation 47 (1989): 106-113.
  38. Mauer SM., et al. “Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus”. The New England Journal of Medicine 295 (1976): 916-920.
  39. Hecking M., et al. “European-New-Onset Diabetes After Transplantation Working Group. Novel views on new onset diabetes after transplantation: development, prevention and treatmen”. Nephrology Dialysis Transplantation 28 (2013): 550-566.
  40. Dronavalli S., et al. “The pathogenesis of diabetic nephropathy”. Nature Clinical Practice Endocrinology and Metabolism 4 (2008): 444-452.
  41. Brownlee M. “The pathobiology of diabetic complications: a unifying mechanism”. Diabetes 54 (2005): 1615-1625.
  42. Valencia WM and Florez H. “How to prevent the microvascular complications of type 2 diabetes beyond glucose control [published correction appears in”. BMJ 356 (2017): i6505.
  43. Terami N., et al. “Long term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice”. PLoS One 9 (2014): e100777.
  44. Vallon V., et al. “SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice”. American Journal of Renal Physiology 306 (2014): F194-F204.
  45. De Nicola L., et al. “Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes”. American Journal of Kidney Diseases 64 (2014): 16-24.
  46. Hatanaka T., et al. “Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice”. Pharmacology Research and Perspectives 4 (2016): e00239.
  47. Cooper M and Warren AM. “A promising outlook for diabetic kidney disease”. Nature Reviews Nephrology 15 (2019): 68-70.
  48. Christiansen JS., et al. “Increased kidney size, glomerular filtration rate and renal plasma flow in short term insulin-dependent diabetics”. Diabetologia 20 (1981): 451-456.
  49. Hostetter TH., et al. “The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies”. The American Journal of Medicine 72 (1982): 375-380.
  50. Zatz R., et al. “Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy”. Proceedings of the National Academy of Sciences of the United States of America 82 (1985): 5963-5967.
  51. Nelson RG., et al. “Diabetic Renal Disease Study Group. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus”. The New England Journal of Medicine 335 (1996): 1636-1642.
  52. Amin R., et al. “The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study”. Kidney International 68 (2005): 1740-1749.
  53. Magee GM., et al. “Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis”. Diabetologia 52 (2009): 691-697.
  54. Ruggenenti P., et al. “GFR Study Investigators. Glomerular hyperfiltration and renal disease progression in type 2 diabetes”. Diabetes Care 35 (2012): 2061-2068.
  55. Lorenzo V., et al. “Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria”. Nephrology Dialysis Transplantation 25 (2012): 835-841.
Citation: Mahmoud Mansour., et al. “Incidence of Renal Nephropathy after Kidney Transplantation in Patients with or without Pre-Transplant Type II Diabetes”. EC Diabetes and Metabolic Research 6.1 (2022): 01-16.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.